Jpmorgan Chase & CO Night Hawk Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.15 - $0.45 $277 - $832	-1,851 Reduced 68.43%	854 $0
Q4 2023 Feb 12, 2024	BUY	$0.26 - $0.51 $356 - $700	1,373 Added 103.08%	2,705 $1,000
Q3 2023 Nov 14, 2023	SELL	$0.5 - $0.72 $75 - $108	-150 Reduced 10.12%	1,332 $0
Q2 2023 Aug 11, 2023	BUY	$0.62 - $0.87 $898 - $1,260	1,449 Added 4390.91%	1,482 $0
Q4 2022 Feb 13, 2023	SELL	$0.77 - $1.62 $9 - $19	-12 Reduced 26.67%	33 $0
Q3 2022 Nov 14, 2022	BUY	$1.79 - $2.96 $80 - $133	45 New	45 $0

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.